Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1726 AL 1740

Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case report

Imbriani P, Schirinzi T, D'Elia A, Pisani A.

Acta Biomed. 2017 Aug 23;88(2):190-195. doi: 10.23750/abm.v88i2.5038.

Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson's disease

Müller T.

Expert Opin Pharmacother. 2017 Oct;18(14):1457-1465. doi: 10.1080/14656566.2017.1373089. Epub 2017 Sep 8.

Pharmacologic Considerations during the Preoperative Evaluation of Neurologic Patients

Mabry C.

Curr Clin Pharmacol. 2017;12(3):176-181. doi: 10.2174/1574884712666170829115133.

Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study

Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Kadowaki T, Hirata K; Kanto NMPD investigators.

J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):953-959. doi: 10.1136/jnnp-2017-316136. Epub 2017 Aug 28.

Fistulization of J-PEG Jejunal Tube into the Colon in a Patient Treated with Duodopa® Infusion: A Case Report

Russo P, Costa M, Silva M, de Sousa A, Carvalho D, Saiote J, Mendes M.

GE Port J Gastroenterol. 2017 May;24(3):147-150. doi: 10.1159/000452694. Epub 2017 Jan 19.

Clinical utility and research frontiers of neuroimaging in movement disorders

Nobili F, Westman E, Kogan RV, Pereira JB, Massa F, Grazzini M, Meles SK, Leenders KL.

Q J Nucl Med Mol Imaging. 2017 Dec;61(4):372-385. doi: 10.23736/S1824-4785.17.03018-7. Epub 2017 Aug 28.

Wearable technology for patients with brain and spinal cord injuries

Burns A, Adeli H.

Rev Neurosci. 2017 Nov 27;28(8):913-920. doi: 10.1515/revneuro-2017-0035.

Are exosomes the vehicle for protein aggregate propagation in neurodegenerative diseases?

Lim YJ, Lee SJ.

Acta Neuropathol Commun. 2017 Aug 29;5(1):64. doi: 10.1186/s40478-017-0467-z.

The PD COMM trial: a protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson's disease

Masterson-Algar P, Burton CR, Brady MC, Nicoll A, Clarke CE, Rick C, Hughes M, Au P, Smith CH, Sackley CM.

Trials. 2017 Aug 29;18(1):397. doi: 10.1186/s13063-017-2130-1.

X-linked Parkinsonism with Intellectual Disability caused by novel mutations and somatic mosaicism in RAB39B gene

Ciammola A, Carrera P, Di Fonzo A, Sassone J, Villa R, Poletti B, Ferrari M, Girotti F, Monfrini E, Buongarzone G, Silani V, Cinnante CM, Mignogna ML, D'Adamo P, Bonati MT.

Parkinsonism Relat Disord. 2017 Nov;44:142-146. doi: 10.1016/j.parkreldis.2017.08.021. Epub 2017 Aug 26.

Influence of gut microbiota on neuropsychiatric disorders

Cenit MC, Sanz Y, Codoñer-Franch P.

World J Gastroenterol. 2017 Aug 14;23(30):5486-5498. doi: 10.3748/wjg.v23.i30.5486.

Umbilical cord: an unlimited source of cells differentiable towards dopaminergic neurons

Boroujeni ME, Gardaneh M.

Neural Regen Res. 2017 Jul;12(7):1186-1192. doi: 10.4103/1673-5374.211201.

Endoplasmic reticulum-mitochondria tethering in neurodegenerative diseases

Liu Y, Zhu X.

Transl Neurodegener. 2017 Aug 23;6:21. doi: 10.1186/s40035-017-0092-6. eCollection 2017.

Treatment gaps in Parkinson's disease care in the Philippines

Jamora RDG, Miyasaki JM.

Neurodegener Dis Manag. 2017 Aug;7(4):245-251. doi: 10.2217/nmt-2017-0014. Epub 2017 Aug 30.

Abnormalities of Dopamine D(3) Receptor Signaling in the Diseased Brain

Prieto GA.

J Cent Nerv Syst Dis. 2017 Aug 16;9:1179573517726335. doi: 10.1177/1179573517726335. eCollection 2017.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias